Prenosis
Chicago · Founded 2014
About Prenosis
Prenosis, Inc. is an artificial intelligence company enabling precision medicine in acute care. At Prenosis we believe healthcare should be tailored to individual biology. With our data-driven approach to fast-moving biology in acute care environments, we're ushering in a new era of precision medicine in acute care. Our Immunix™ precision medicine platform generates proprietary biological insights to rapidly develop precision medicine products and enables the real-time delivery of optimal precision therapy in acute care. The platform is based on the world's largest and fastest-growing biomarker-clinical dataset for rapid immune response. Using Immunix™, we created and validated the Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis. At Prenosis, we enable the healthcare ecosystem to see people differently. More information at: www.prenosis.com
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: http://www.prenosis.com
- Phone: (949)246-3113
Industries & Categories
Artificial Intelligence (AI), Biopharma, Health Care, Hospital, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/prenosis-18900 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.